An asymptomatic 32-year-old female is undergoing preoperative laboratory evaluation before… — USMLE Step 3

An asymptomatic $32$ -year-old female is undergoing preoperative laboratory evaluation before a scheduled elective laparoscopic cystectomy for a benign ovarian cyst. She reports no prior surgeries, heavy menses, excessive bruising, or family history of bleeding disorders. Her physical examination is unremarkable.

Vital signs are within normal limits.

Laboratory results are as follows:

Test	Result	Reference Range
Hemoglobin	$13.2 \text{ g/dL}$	$12.0-16.0 \text{ g/dL}$
Platelet count	$240,000/\mu\text{L}$	$150,000-400,000/\mu\text{L}$
Prothrombin time (PT)	$12.5 \text{ seconds}$	$11.0-15.0 \text{ seconds}$
Activated partial thromboplastin time (aPTT)	$62 \text{ seconds}$	$25-40 \text{ seconds}$

A mixing study is performed using a $1:1$ mixture of the patient's plasma and pooled normal plasma:

Condition	Result
Immediate aPTT	$58 \text{ seconds}$
2-hour incubated aPTT	$60 \text{ seconds}$

Which of the following is the most likely explanation for this patient's laboratory findings?

Presence of an antiphospholipid antibodyAnswer
B
Acquired autoantibody against Factor VIII
C
Congenital deficiency of Factor VIII
D
Quantitative deficiency of von Willebrand factor
E
Consumptive coagulopathy

Answer

Presence of an antiphospholipid antibody (specifically the lupus anticoagulant)

The patient presents with an isolated prolonged aPTT. The next appropriate step in evaluating an isolated aPTT prolongation is a mixing study. If the aPTT corrects, it indicates a factor deficiency (e.g., Factor VIII, IX, or XI deficiency). If it fails to correct, it indicates the presence of an inhibitor. This patient's aPTT failed to correct, confirming an inhibitor. There are two main types of inhibitors: specific factor autoantibodies (like an acquired Factor VIII inhibitor) and non-specific inhibitors (like the lupus anticoagulant, an antiphospholipid antibody). Acquired factor inhibitors cause severe, life-threatening bleeding. The lupus anticoagulant, conversely, interferes with the phospholipid-dependent aPTT assay in the laboratory but does not cause a bleeding diathesis in vivo (it is paradoxically associated with thrombosis). Given this patient is entirely asymptomatic with no bleeding history, the presence of an antiphospholipid antibody is the most likely explanation.

Step-by-Step Solution

Analyze the initial coagulation panel.

The patient has an isolated prolongation of the activated partial thromboplastin time (aPTT) with a normal prothrombin time (PT) and a normal platelet count.

Identifying the specific pathway abnormality (intrinsic vs. extrinsic) narrows the differential diagnosis.

Interpret the mixing study results.

The

1:1

mixture of the patient's plasma with normal plasma fails to correct the aPTT to within the normal range (

25-40 \text{ seconds}

), both immediately and after a 2-hour incubation.

A mixing study differentiates between a factor deficiency (which corrects with normal plasma) and a factor inhibitor (which fails to correct because the inhibitor neutralizes the added factors).

Correlate the laboratory findings with the clinical presentation.

The patient has an inhibitor pattern on laboratory testing but is completely asymptomatic without any history of bleeding.

Specific factor inhibitors (e.g., Factor VIII autoantibodies) cause severe clinical bleeding. In contrast, the lupus anticoagulant (an antiphospholipid antibody) binds to phospholipids in the assay, causing artifactual in vitro aPTT prolongation that fails to correct, but it does not cause bleeding in vivo (it is actually prothrombotic).

Key Concept

Interpretation of aPTT mixing studies and clinical correlation of isolated aPTT prolongation.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic